Sally Amanuel

President, PrimeVigilance

Sally has over 20 years of experience working in Regulatory Affairs and Compliance.

As a regulatory expert, she has a proven track record in driving transformational changes and delivering business results in highly regulated environments across Pharma, Biotech and CRO industries.

In her earlier role at Ergomed as the Head of the Regulatory Affairs and Clinical Delivery, Sally was responsible for integrating the CRO Regulatory function within PrimeVigilance, consolidating the PV Network, XEVMPD, Regulatory Intelligence and Regulatory Affairs teams.

Prior to joining Ergomed, Sally held numerous leadership positions at WCT, PPD and Syneos, Biogen, Pfizer and GSK, where she led several successful turnarounds, redesigned and expanded service capabilities to exceed revenue targets and provided executive leadership on numerous companywide change initiatives.

Sally gained a BSc in Biotechnology from University College London (UCL), an MA in Biotechnological Law and Ethics from the University of Sheffield, and an MBA from the University of Liverpool.

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services